Back to Search
JUSTIN MAXHIMER, M.D.
M.D.
Plastic Surgery Physician
NPI: 1720138639IndividualAccepts Medicare
Specialties, Licenses & Credentials
Plastic Surgery PhysicianPrimary
Plastic Surgery
Code: 208200000X
DR54921(CO)
CMS Specialties
Education
RUSH MEDICAL COLLEGE OF RUSH UNIVERSITY
Class of 2005
Research & Publications (20)
Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients.
PMID 15983219·Diabetes·2005
8-other
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C).
PMID 15632825·J Thorac Cardiovasc Surg·2005
4-observational
Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress.
PMID 19284971·Matrix Biol·2009
7-preclinical
Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.
PMID 19194382·Nat Rev Cancer·2009
6-review
Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.
PMID 19081017·Surgery·2008
7-preclinical
Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.
PMID 18787106·Am J Pathol·2008
7-preclinical
Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.
PMID 18438125·Ann Surg·2008
7-preclinical
Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade.
PMID 17136498·Apoptosis·2007
8-other
Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation.
PMID 16820090·Neoplasia·2006
8-other
Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01.
PMID 16705314·Br J Cancer·2006
4-observational
Surgical management of well-differentiated thyroid cancer locally invasive to the respiratory tract.
PMID 16183503·J Am Coll Surg·2005
6-review
The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro.
PMID 15867774·J Thorac Cardiovasc Surg·2005
8-other
Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.
PMID 15737842·J Am Coll Surg·2005
4-observational
Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
PMID 15573073·J Thorac Cardiovasc Surg·2004
8-other
Outcome of laparoscopic adrenalectomy for pheochromocytomas vs aldosteronomas.
PMID 15136353·Arch Surg·2004
8-other
Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
PMID 14676122·Clin Cancer Res·2003
8-other
Central pancreatectomy for the resection of benign or low malignant potential neoplasms.
PMID 12715230·World J Surg·2003
5-case
Differential heparanase-1 expression in malignant and benign pheochromocytomas.
PMID 12443714·J Surg Res·2002
8-other
Vascular complications associated with pancreaticoduodenectomy adversely affect clinical outcome.
PMID 12407360·Surgery·2002
4-observational
Heparanase-1 expression is associated with the metastatic potential of breast cancer.
PMID 12219030·Surgery·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1215 SPRUCE ST STE 201
BOULDER, CO 80302 - Phone
- (303) 443-2277
Quick Facts
- NPI
- 1720138639
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile